Related Experiment Video
Updated: Jul 14, 2026
Analysis of Cardiac Chamber Development During Mouse Embryogenesis Using Whole Mount Epifluorescence
Published on: April 17, 2019
Myocardial smad4 is essential for cardiogenesis in mouse embryos
Lanying Song1, Wensheng Yan, Xinbin Chen
1Department of Genetics, Division of Genetic and Translational Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Insights
Smad4 is essential for heart development. Its disruption in mice caused heart failure and embryonic lethality due to a hypocellular myocardial wall, contradicting previous findings and highlighting Smad4
Area of Science:
- Developmental Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Congenital heart diseases are leading causes of infant mortality.
- Transforming growth factor-beta/bone morphogenetic protein (TGF-β/BMP) signaling is crucial for heart development.
- Smad4 is a key mediator in TGF-β/BMP signaling pathways.
Purpose of the Study:
- To investigate the role of Smad4 in heart development.
- To create a mouse model to study Smad4 function in the myocardium.
Main Methods:
- Generation of a conditional knockout mouse model by disrupting Smad4 specifically in the myocardium using a Cre/loxP system.
- Histological analysis to examine myocardial wall defects.
- Molecular analyses including reporter assays and chromatin immunoprecipitation to identify downstream targets.
Main Results:
- Myocardial-specific Smad4 inactivation led to embryonic lethality and heart failure.
- Mutant embryos exhibited a hypocellular myocardial wall defect, characterized by reduced cell proliferation and increased apoptosis.
- Downregulation of Nmyc and its targets (cyclin D1, D2, Id2) was observed; Nmyc is identified as a direct Smad4 target.
Conclusions:
- Smad4 plays an essential and non-redundant role in mammalian cardiogenesis.
- The study provides the first mouse model demonstrating Smad4's critical function during heart development.
- Findings contradict previous reports suggesting Smad4 is dispensable for heart development.
Abstract:
Congenital heart diseases are the most commonly observed human birth defects and are the leading cause of infant morbidity and mortality. Accumulating evidence indicates that transforming growth factor-beta/bone morphogenetic protein signaling pathways play critical roles during cardiogenesis. Smad4 encodes the only common Smad protein in mammals, which is a critical nuclear mediator of transforming growth factor-beta/bone morphogenetic protein signaling. The aim of this work was to investigate the roles of Smad4 during heart development. To overcome the early embryonic lethality of Smad4(-/-) mice, we specifically disrupted Smad4 in the myocardium using a Cre/loxP system. We show that myocardial-specific inactivation of Smad4 caused heart failure and embryonic lethality at midgestation. Histological analysis revealed that mutant mice displayed a hypocellular myocardial wall defect, which is likely the primary cause for heart failure. Both decreased cell proliferation and increased apoptosis contributed to the myocardial wall defect in mutant mice. Data presented in this article contradict a previous report showing that Smad4 is dispensable for heart development. Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos. Reporter analysis indicated that the transcriptional activity of the 351-bp Nmyc promoter can be positively regulated by bone morphogenetic protein stimulation and negatively regulated by transforming growth factor-beta stimulation. Chromatin immunoprecipitation analysis revealed that the Nmyc promoter can form a complex with Smad4, suggesting that Nmyc is a direct downstream target of Smad4. In conclusion, this study provides the first mouse model showing that Smad4 plays essential roles during cardiogenesis.
